研究关注：ASGCT 2026: Victoria Gray Roadshow Returns to Boston

## 事件概览

Sickle cell warrior Victoria Gray, the first patient to enroll in the Casgevy gene editing trial, shared some highs and lows from her person...

## 核心信息

Sickle cell warrior Victoria Gray, the first patient to enroll in the Casgevy gene editing trial, shared some highs and lows from her personal story and unveiled her first children's book. Gray was a special guest of the Emily Whitehead Foundation and ScaleReady. The post ASGCT 2026: Victoria Gray Roadshow Returns to Boston appeared first on GEN - Genetic Engineering and Biotechnology News .

## 为什么值得关注

这条内容与 cell biology 相关，可能影响科研选题、技术趋势判断或产业观察。BioDir 已根据来源、摘要长度、主题词和潜在影响给出 43 分的候选评分。

## 发布提示

发布前应核对原文链接、研究对象、样本规模、方法限制和结论边界。若来源为 bioRxiv 或 medRxiv，应明确标注其为预印本，尚未经过同行评议。